Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease
Srinevas K. Reddy, Jennifer L. Steel, Hui‐Wei Chen, David J. DeMateo, Jon Cardinal, Jaideep Behari, Abhinav Humar, J. Wallis Marsh, David A. Geller, Allan Tsung – 20 December 2011 – Concomitant increasing incidences of hepatocellular carcinoma (HCC) and nonalcoholic steatohepatitis (NASH) suggest that a substantial proportion of HCC arises as a result of hepatocellular injury from NASH.